{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T06:47:18Z","timestamp":1776840438010,"version":"3.51.2"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Lung transplantation is a definitive lifesaving option for end-stage lung disease; however, its role in rapidly progressive interstitial lung disease (RP-ILD) associated with anti\u2013melanoma differentiation-associated gene 5 (anti-MDA5) antibodies remains debated. We retrospectively analyzed two anti-MDA5\u2013positive RP-ILD (MDA5\n                    <jats:sup>+<\/jats:sup>\n                    RP-ILD) patients who underwent bilateral lung transplantation and synthesized pertinent literature to evaluate clinical value and the impact of therapeutic interventions. Both patients recovered postoperatively and were discharged after symptomatic management and supportive care. One patient subsequently developed cerebral infarction and died approximately 8 months after transplantation, whereas the other remains clinically stable under regular follow-up. Given the limited efficacy of conventional therapies and the overall poor prognosis of anti-MDA5-positive dermatomyositis (MDA5\n                    <jats:sup>+<\/jats:sup>\n                    DM) with RP-ILD, our observations-together with prior reports\u2014support lung transplantation, with extracorporeal membrane oxygenation (ECMO) as a bridge when necessary, as a promising and reliable therapeutic strategy. Lung transplantation may offer definitive treatment in carefully selected patients, underscoring its important clinical value.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2026.1817318","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T05:49:25Z","timestamp":1776836965000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Lung transplantation for rare anti-MDA5\u2013positive rapidly progressive interstitial lung disease: two cases and a narrative review"],"prefix":"10.3389","volume":"17","author":[{"given":"Qing","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Surgery, The First Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-dong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Surgery, The First Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Organ Transplantation Center, The First Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13075-025-03485-z","article-title":"Clinical features and survival analysis of 40 cases of anti-MDA5 antibody-positive dermatomyositis complicated with interstitial lung disease","volume":"27","author":"Zhao","year":"2025","journal-title":"Arthritis Res Ther"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2022.151959","article-title":"Management of MDA-5 antibody positive clinically amyopathic dermatomyositis associated interstitial lung disease: a systematic review","volume":"53","author":"McPherson","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"B3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/24725625.2020.1826641","article-title":"Early initiation of plasma exchange therapy for a patient with anti-MDA5 autoantibody-positive dermatomyositis developing rapidly progressive interstitial lung disease","volume":"5","author":"Sasaki","year":"2021","journal-title":"Mod Rheumatol Case Rep"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.576436","article-title":"Fulminant course of neuromyelitis optica in a patient with anti-MDA5 antibody-positive dermatomyositis: a case report","volume":"7","author":"Kang","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1568338","article-title":"A pilot transcriptomic study of a novel multitargeted BRT regimen for anti-MDA5 antibody-positive dermatomyositis: improving survival over conventional therapy","volume":"16","author":"Tokunaga","year":"2025","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s12016-020-08822-5","article-title":"Interstitial lung disease in anti-MDA5 positive dermatomyositis","volume":"60","author":"Wu","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.733599","article-title":"A clinical risk model to predict rapidly progressive interstitial lung disease incidence in dermatomyositis","volume":"8","author":"Li","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/bor.0000000000000908","article-title":"Anti-MDA5 dermatomyositis: an update from bench to bedside","volume":"34","author":"Fuzzi","year":"2022","journal-title":"Curr Opin Rheumatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/mcp.0000000000001000","article-title":"Myositis-associated interstitial lung disease","volume":"29","author":"Vu","year":"2023","journal-title":"Curr Opin Pulm Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11926-025-01188-7","article-title":"Anti- melanoma differentiation-associated gene 5 antibody positive dermatomyositis: recent progress in pathophysiology and treatment","volume":"27","author":"Yoshida","year":"2025","journal-title":"Curr Rheumatol Rep"},{"key":"B11","doi-asserted-by":"publisher","first-page":"25537","DOI":"10.1038\/s41598-025-10895-1","article-title":"Dysregulated type I\/III interferon system in circulation from patients with anti-MDA5-positive dermatomyositis","volume":"15","author":"Yoshida","year":"2025","journal-title":"Sci Rep"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.833114","article-title":"Pathogenesis of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: a concise review with an emphasis on type I interferon system","volume":"8","author":"Hu","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.743704","article-title":"RNA-containing immune complexes formed by anti-melanoma differentiation associated gene 5 autoantibody are potent inducers of IFN-alpha","volume":"12","author":"Wang","year":"2021","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s13075-025-03600-0","article-title":"Anti-interferon-alpha antibodies associate with disease activity and prognosis in anti-MDA5-positive dermatomyositis","volume":"27","author":"Sun","year":"2025","journal-title":"Arthritis Res Ther"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keae183","article-title":"The clinical relevance of WDFY4 in autoimmune diseases in diverse ancestral populations","volume":"63","author":"Lyu","year":"2024","journal-title":"Rheumatol (Oxford)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez357","article-title":"Successful treatment of anti-MDA5 antibody-positive refractory interstitial lung disease with plasma exchange therapy","volume":"59","author":"Abe","year":"2020","journal-title":"Rheumatol (Oxford)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead006","article-title":"WDFY4 polymorphisms in Chinese patients with anti-MDA5 dermatomyositis is associated with rapid progressive interstitial lung disease","volume":"62","author":"Guo","year":"2023","journal-title":"Rheumatol (Oxford)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000042536","article-title":"Anti-MDA5 antibody positive dermatomyositis complicated by interstitial lung disease with an improved outcome: a case report","volume":"104","author":"Jiang","year":"2025","journal-title":"Med (Baltimore)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead117","article-title":"IFN-beta and EIF2AK2 are potential biomarkers for interstitial lung disease in anti-MDA5 positive dermatomyositis","volume":"62","author":"Liu","year":"2023","journal-title":"Rheumatol (Oxford)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13023-021-01705-8","article-title":"Initial predictors for short-term prognosis in anti-melanoma differentiation-associated protein-5 positive patients","volume":"16","author":"Yang","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.20850","article-title":"Risk stratification in anti-MDA5+ dermatomyositis-related interstitial lung disease by using cluster analysis","volume":"40","author":"He","year":"2026","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s40674-021-00186-x","article-title":"Pharmacologic treatment of anti-MDA5 rapidly progressive interstitial lung disease","volume":"7","author":"Selva-O'Callaghan","year":"2021","journal-title":"Curr Treatm Opt Rheumatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/jmpuxa","article-title":"Triple-combination therapy did not improve prognosis in anti-MDA5 positive dermatomyositis: a multicentre longitudinal cohort study","volume":"43","author":"You","year":"2025","journal-title":"Clin Exp Rheumatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.585761","article-title":"Iacta alea est: the inexorable advance of tofacitinib in the treatment of dermatomyositis-associated rapidly progressive interstitial lung disease. a case report","volume":"11","author":"Conca","year":"2020","journal-title":"Front Pharmacol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002795","article-title":"Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis","volume":"9","author":"Ida","year":"2023","journal-title":"RMD Open"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2500446","DOI":"10.1183\/13993003.00446-2025","article-title":"How to treat patients with MDA5-associated rapidly progressive interstitial lung disease? Which immunosuppressive therapy for which patients","volume":"66","author":"Uzunhan","year":"2025","journal-title":"Eur Respir J"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.medj.2025.100802","article-title":"Efficacy of JAK inhibitor combined with protein A immunoadsorption in MDA5+ dermatomyositis with RPILD: a real-world study","volume":"6","author":"Fu","year":"2025","journal-title":"Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-022-06422-6","article-title":"Lung transplantation for anti-MDA5-positive dermatomyositis-associated rapid progressive interstitial lung disease: report of two cases and review of the literature","volume":"42","author":"Lian","year":"2023","journal-title":"Clin Rheumatol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2021.08.012","article-title":"High-emergency lung transplantation for interstitial lung disease associated with anti-MDA5 dermatomyositis: a case report","volume":"53","author":"Marchiset","year":"2021","journal-title":"Transplant Proc"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2102968","DOI":"10.1183\/13993003.02968-2021","article-title":"Extracorporeal life support allows lung transplant in anti-MDA5+ rapidly progressive interstitial lung disease","volume":"59","author":"Bay","year":"2022","journal-title":"Eur Respir J"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab305","article-title":"Forced vital capacity predicts the survival of interstitial lung disease in anti-MDA5 positive dermatomyositis: a multi-centre cohort study","volume":"61","author":"Wu","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"B32","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12931-025-03347-x","article-title":"Spontaneous pneumomediastinum and\/or pneumothorax in anti-MDA5 dermatomyositis: a refined staging system","volume":"26","author":"Jin","year":"2025","journal-title":"Respir Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa032","article-title":"Successful lung transplant in rapid progressive interstitial lung disease associated with anti-melanoma differentiation associated gene 5","volume":"59","author":"Huang","year":"2020","journal-title":"Rheumatol (Oxford)"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.08.004","article-title":"The immunostimulatory RNA RN7SL1 enables CAR-T cells to enhance autonomous and endogenous immune function","volume":"184","author":"Johnson","year":"2021","journal-title":"Cell"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaf259","article-title":"Long-term outcomes in lung transplant for anti-melanoma differentiation-associated gene 5 (anti-MDA5) antibody positive interstitial lung disease: a case series","volume":"64","author":"Jade","year":"2025","journal-title":"Rheumatol (Oxford)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10123176","article-title":"Infection risk in patients with dermatomyositis associated with anti-MDA5 antibodies: a historical cohort study","volume":"10","author":"Billet","year":"2022","journal-title":"Biomedicines"},{"key":"B37","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41584-023-01054-9","article-title":"Anti-MDA5 antibody-positive dermatomyositis: pathogenesis and clinical progress","volume":"20","author":"Lu","year":"2024","journal-title":"Nat Rev Rheumatol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1697803","article-title":"Exhaustion of NK cells and interferon activation in anti-MDA5(+) dermatomyositis are associated and determine the development of ILD","volume":"16","author":"Shao","year":"2025","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-021-04819-1","article-title":"Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry","volume":"41","author":"Mehta","year":"2021","journal-title":"Rheumatol Int"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.92a.25018","article-title":"MDA5 dermatomyositis: unveiling a potentially life-threatening disease","volume":"92","author":"Chatterjee","year":"2025","journal-title":"Cleve Clin J Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac627","article-title":"Changes in anti-MDA5 antibody titres and serum cytokine levels before and after diagnosis of anti-MDA5 antibody-positive dermatomyositis","volume":"62","author":"Kogami","year":"2023","journal-title":"Rheumatol (Oxford)"},{"key":"B42","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/bjd.14882","article-title":"Antimelanoma differentiation-associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis","volume":"176","author":"Matsushita","year":"2017","journal-title":"Br J Dermatol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s12975-024-01236-x","article-title":"Type I interferon signalling and ischemic stroke: mechanisms and therapeutic potentials","volume":"16","author":"Cui","year":"2025","journal-title":"Transl Stroke Res"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1148069","article-title":"Interferon-beta modulates microglial polarization to ameliorate delayed tPA-exacerbated brain injury in ischemic stroke","volume":"14","author":"Kuo","year":"2023","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1817318\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T05:49:31Z","timestamp":1776836971000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1817318\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":44,"alternative-id":["10.3389\/fimmu.2026.1817318"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1817318","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"article-number":"1817318"}}